News Results for Astrazeneca (AZN)

Pharma giant AstraZeneca said its drug to treat neurofibromatosis type 1, a rare and debilitating genetic disease, had been granted orphan drug designation in Japan. Selumetinib, neurofibromatosis...

Oddo today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to reduce (from buy) and cut its price target to 7600p (from 8100p). Story provided by StockMarketWire.com Broker...

The FTSE 100 recovered some ground by lunchtime on Monday to trade back above the 6,000 mark, though there is still plenty of nervousness around about a second wave in the coronavirus pandemic...

Drugmaker AstraZeneca said it had reached an agreement with Europe's Inclusive Vaccines Alliance to supply up to 400m doses of the University of Oxford's COVID-19 vaccine. Deliveries of the...

The FTSE 100 ended Monday in the red after a mixed day for the index saw optimism over an economic recovery offset by investors' profit taking and pharmaceutical giant AstraZeneca falling on merger...

The FTSE 100 moved into positive territory by lunchtime on Monday as optimism over a recovery increased across various sectors, including airlines and housebuilders. The UK's benchmark index...

AstraZeneca fell after Bloomberg News reported that the pharma giant had approached rival Gilead about a potential merger. The companies were not in formal talks as AstraZeneca didn't specify...

UK stocks opened lower on Monday as investors took profits on a recent recovery rally and pharmaceutical company AstraZeneca fell on merger talk. At 0830, the benchmark FTSE 100 index was down...

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7300p (from 6000p). Story provided by StockMarketWire.com Broker Forecasts data provided...

Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9100p (from 8780p). Story provided by StockMarketWire.com Broker Forecasts data...

UK stocks were higher on Monday as companies continued to restart operations and open stores as lockdowns eased, offsetting tensions caused by ongoing rioting in the US. At 11.35, the benchmark...

UK stocks opened substantially higher on Monday as companies continued to restart operations and open stores as lockdowns eased, offsetting tensions caused by ongoing rioting in the US. At 0820,...

Pharma giant AstraZeneca said its cancer drug had been recommended for marketing authorisation in the European Union to treat patients with metastatic pancreatic cancer. The Committee for...

The FTSE 100 tailed off sharply on Friday afternoon as fears mounted that US president Donald Trump will retaliate against China over a sweeping national security law it approved for Hong Kong....

Pharmaceutical company AstraZeneca said a venture with Daiichi Sankyo had recorded positive clinical trial results for a gastric cancer treatment. The trial showed that the trastuzumab deruxtecan...

The FTSE 100 gave back most of the previous day's gains on Friday as investors prepared for US president Donald Trump to outline America's response to political tensions in Hong Kong that are...

UK stocks opened lower on Friday as investors prepared for Donald Trump to outline America's response to political tensions in Hong Kong that are further straining US-Sino relations. At 0822, the...

Pharma giant AstraZeneca said a clinical trial of a drug to treat non-small cell lung cancer showed the drug had reduced the risk of disease recurrence or death by about 80%. Detailed results...

Drug companies AstraZeneca and Daiichi Sankyo said a drug to treat patients with gastric cancer, including gastroesophageal junction cancer, had been granted orphan drug designation in the US....

The FTSE 100 fell on Thursday as the number of COVID-19 cases globally is reported to have exceeded 5 million, according to data from John Hopkins University. Meanwhile, the UK government remains...

The FTSE 100 traded lower midday Thursday as the number of COVID-19 cases globally is reported to have exceeded 5 million, according to data from John Hopkins University. Meanwhile, the UK...

The FTSE 100 has opened lower as the number of COVID-19 cases globally is reported to have exceeded 5 million, according to data from John Hopkins University. Meanwhile, the UK government remains...

Pharma giant AstraZeneca said it would begin first deliveries of the University of Oxford's potential coronavirus vaccine in September 2020 after it received $1 billion from a US government agency...

UK markets staged a stunning afternoon recovery on Wednesday, reversing morning losses. Having spent most of the morning session firmly in the red and dipping back below 6,000, the FTSE 100 leapt...

UK markets managed to reverse early morning losses on Wednesday to nudge modestly into positive territory at midday, but there remains plenty for investors to mull over. Doubts have quickly...

UK stocks opened lower on Wednesday as doubts emerged about the potential effectiveness of a Covid-19 vaccine being developed by Morderna. At 0821, the benchmark FTSE 100 index was down 18.3...

Pharma giant AstraZeneca said its prostate cancer treatment had been approved in the US. The approval by the US Food and Drug Administration (FDA) was based on results from a Phase III PROfound...

The FTSE 100 passed an important psychological hurdle on Monday as it jumped over the 6,000 mark for the first time in almost three weeks amid positive news from a coronavirus vaccine trial. The...

UK stocks made strong gains on Monday as more countries continued to take tentative steps to emerge from coronavirus lockdowns. A surge in oil prices also helped, along with data which showed that...

UK stocks made strong gains in early trade on Monday as more countries continued to take tentative steps to emerge from Covid-19 lockdowns. At 0819, the benchmark FTSE 100 index was up 133.63...

Pharma giant AstraZeneca said its chronic obstructive pulmonary disease treatment had been approved in China. The company also said its non-small cell lung cancer treatment had been granted...

UK stocks ended Monday effectively flat as traders digested the government's plans to reopen the economy. The threat of a second wave of infections in reopening countries like Germany, South Korea...

Despite an early rally UK stocks fell into the red by mid-morning on Monday as uncertainty gripped markets ahead of the government's new coronavirus guidance. The government will publish the full...

Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8780p (from 8550p). Story provided by StockMarketWire.com Broker Forecasts data...

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7575p). Story provided by StockMarketWire.com Broker...

UK stocks opened higher on Monday as investors embraced moves by governments around the world to ease Covid-19 lockdown measures. At 0824, the benchmark FTSE 100 index was up 53.83 points, or...

Pharma giant AstraZeneca reported positive news on the progress of its gastric and ovarian cancer drugs in the US. The company also said it had completed the recovery of the global rights to...

Drugmaker AstraZeneca said its heart failure drug to reduce the risk of cardiovascular death and hospitalisation had been approved in the US. The approval by the Food and Drug Administration was...

DZ Bank today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7300p (from 6500p). Story provided by StockMarketWire.com Broker Forecasts data...

JP Morgan Cazenove today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 8500p). Story provided by StockMarketWire.com Broker...

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9200p (from 9000p). Story provided by StockMarketWire.com Broker...

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9000p (from 8500p). Story provided by StockMarketWire.com Broker...

HSBC today reaffirms its reduce investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6690p (from 6450p). Story provided by StockMarketWire.com Broker Forecasts data...

AstraZeneca reported a rise in first-quarter revenue boosted by sales of new medicines. The pharma giant also said it was evaluating drugs to curb the health impact of the Covid-19 virus. Total...

UK stocks closed lower on Friday after news that trial data indicated a potential treatment for Covid-19 being developed by Gilead Sciences didn't improve patients' conditions. Local stocks were...

UK stocks traded lower on Friday lunchtime after trial data indicated a potential treatment for Covid-19 being developed by Gilead Sciences didn't improve patients' conditions. Local stocks were...

Pharma giant AstraZeneca released further positive results from a clinical trial of a drug used to treat men with metastatic castration-resistant prostate cancer. Results from the trial showed a...

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts...

Mainfirst today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8800p (from 8100p). Story provided by StockMarketWire.com Broker Forecasts data...

Morgan Stanley today reaffirms its equal weight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8600p (from 8250p). Story provided by StockMarketWire.com Broker...

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7575p (from 7475p). Story provided by StockMarketWire.com Broker...

UK stocks resumed trading after an extended Easter break, closing with losses on Tuesday, despite signs Covid-19 infection rates were stabilizing in major disease hotspots. At 16:30, the benchmark...

UK stocks resumed trading after an extended Easter break with losses on Tuesday, largely holding onto gains driven last week by signs Covid-19 infection rates were stabilizing in major disease...

UK stocks resumed trading after an extended Easter break with slight losses on Tuesday, largely holding onto gains driven last week by signs Covid-19 infection rates were stabilizing in major...

Pharma giant Astrazeneca said a trial for its drug used to treat patients with lung cancer would be unblinded early following a recommendation from an Independent Data Monitoring Committee amid...

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8870p (from 8810p). Story provided by StockMarketWire.com Broker Forecasts...

The FTSE 100 had a subdued start, opening 20 points up in early morning trading at 5,461 as the UK continues to take stringent measures in its fight against coronavirus. Italy appeared to...

Pharma giant AstraZeneca said it had completed the previously agreed sale of its global rights to Movantik, a treatment for opioid-induced constipation, to RedHill Biopharma for at least $52.5m....

Oddo today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7600p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by...

Pascal Soriot, Chief Executive Officer, has transferred in 74,698 shares in the company on the 27th March 2020 at a price of 0.00p. The Director now holds 289,032 shares. NOTE: Vesting Story...

Marc Dunoyer, Financial Director, has transferred in 19,429 shares in the company on the 27th March 2020 at a price of 0.00p. The Director now holds 304,991 shares. NOTE: Vesting Story provided...

Pharma giant AstraZeneca's said it drug to treat extensive-stage small cell lung cancer in combination with chemotherapies had been approved in the US. The approval by the Food and Drug...

Pascal Soriot, Chief Executive Officer, has transferred in 7,338 shares in the company on the 24th March 2020 at a price of 0.00p. The Director now holds 214,334 shares. NOTE: Vesting - net of...

Marc Dunoyer, Financial Director, has transferred in 2,344 shares in the company on the 24th March 2020 at a price of 0.00p. The Director now holds 285,562 shares. NOTE: Vesting - net of shares...

Pharma giant AstraZeneca said its treatment for hyperkalaemia, a disease reflecting elevated levels of potassium in the blood, had been approved in Japan. The approval of the company's drug...

Silence Therapeutics said it had formed a strategic collaboration arrangement with AstraZeneca to develop therapeutics for the treatment of cardiovascular, renal, metabolic and respiratory...

After retreating earlier on Tuesday, FTSE rallied back into positive territory in the afternoon following US markets higher after president Trump unveiled more stimulus measures to tackle the virus...

After opening higher on Tuesday, FTSE retreated into negative territory at midday, as investors continued to question how severely the worsening coronavirus outbreak will hurt the global economy....

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8000p (from 8500p). Story provided by StockMarketWire.com Broker...

Pharma giant AstraZeneca said its lung cancer drug in combination with chemotherapies confirmed a clinically meaningful improvement in survival rates for patients with extensive-stage small cell...

The FTSE 100 recorded the second biggest one-day fall in its history on Thursday, as investors increasingly look to sell risk assets. The UK's benchmark index closed down a staggering 10.87%, or...

The FTSE 100 continued on its downward trajectory by midday on Thursday, having hit its lowest point in four years when it closed yesterday. At 1200, the index fell 5.7%, losing 334 points to...

The FTSE 100 continued on its downward trajectory in early morning trading, having hit its lowest point in four years when it closed yesterday. The index fell 5.35%, losing 314 points to reach...

Pharma giant AstraZeneca said its trial of a potential new medicine to treat patients with sensitive relapsed ovarian cancer had failed to meet its primary objective of improving survival rates...

It was an absolute bloodbath for UK shares on Friday as growth fears escalated from the spreading coronavirus outbreak, leaving markets staring down the barrel of a second straight week of losses....

UK stocks plunged again on Friday leaving investors braced for a second straight week of losses as growth fears escalate from the spreading coronavirus outbreak. Even the US Fed rate cut earlier in...

UK stocks fell heavily on Friday as the coronavirus continued to spread rapidly around the world, including in the UK and US. At 0813, the benchmark FTSE 100 index was down 98.94 points, or...

Pharmaceutical company AstraZeneca said its trial for a bladder cancer treatment had failed to meet its primary goal. The trial of the 'stage four' treatment had failed to improve patient...

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6000p (from 5800p). Story provided by StockMarketWire.com Broker Forecasts data provided...

UK stocks had a volatile Monday after surging on central bank stimulus hopes, before plummeting on warnings over global growth and then rising again as the World Bank and International Monetary...

A rally in UK stocks this morning was short lived as the Organisation for Economic Co-operation and Development warned the coronavirus outbreak could halve its 2020 global growth forecast. Shares...

UK stocks rebounded on Monday, having undergone a savaging last week, as investors focused on the potential for co-ordinated global stimulus measures to cushion the impact of the coronovirus. At...

AstraZeneca said it had completed the sale of the global commercial rights of its hypertension medicines to Atnahs Pharma for up to $390m. The divestment was previously announced in late-January....

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8300p (from 8400p). Story provided by StockMarketWire.com Broker Forecasts data...

Pharmaceuticals giant AstraZeneca said it had agreed to sell global rights to a constipation drug excluding Europe, Canada and Israel to RedHill Biopharma for an upfront payment of $52.5m....

Michel Demare, Non Executive Director, bought 700 shares in the company on the 17th February 2020 at a price of 7313.00p. The Director now holds 700 shares representing 0.00% of the shares in...

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7700p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data...

UK markets endured a mixed close to the trading week with the FTSE 100 failing to hold on to mid-Friday gains. An unwelcome warning of downward pressure on Royal Bank of Scotland's income and...

UK markets staged a late morning rally to erase earlier declines as investors turned their attention on upcoming fourth-quarter GDP data from across the Eurozone. This was despite Royal Bank of...

UK stocks opened lower on Friday as the coronavirus death toll continued to climb and Royal Bank of Scotland warned of downward pressure on its income. At 0824, the benchmark FTSE 100 index had...

Pharmaceutical company AstraZeneca posted a 22% fall in annual profit after rising revenue was offset by an increase in selling and other administrative costs. Pre-tax profit for the year through...

UK stocks slumped on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world, prompting fears over the economic impact on the travel and...

UK stocks slumped on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world. At 13.10, the benchmark FTSE 100 index was down 159.4...

UK stocks slumped in early trade on Monday as the Chinese death toll from a coronavirus outbreak rose to 81 and new cases were reported around the world. At 0846, the benchmark FTSE 100 index was...

AstraZeneca said it had agreed to sell the global commercial rights to its hypertension drugs and also said it would recover rights from Allergen to a drug used to treat Crohn's disease. The...

AstraZeneca said its gastric cancer and stroke treatments had met their primary goal in clinical trials. Gastric cancer drug, Enhertu, met its primary endpoint of an improvement in objective...

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8810p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts...

Pharmaceutical company AstraZeneca said its liver cancer treatment had received orphan drug designation from the US Food and Drug Administration. Imfinzi (durvalumab) and tremelimumab, an...

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 8200p). Story provided by StockMarketWire.com Broker...